Budgetary Impact of Covering “Me-Too” Drugs from Social Security: Buenos Aires State Case Report

The majority of new drugs registered at Health Global Market are not considered real innovations and due to their chemical structure similarity of reference’s group drug, they are known as “me-too”. These “me too” drugs usually has no additional therapeutic benefits but greatly increasing treatment...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marín, Gustavo Horacio, Marín, Lupe, Agüero, Daniel, Marin, Gina, Pagnotta, Mariana, Blanco, Luis
Formato: Articulo
Lenguaje:Inglés
Publicado: 2020
Materias:
Ciencias Médicas
Health
Policies
Medicines
Me too
Economical Burden
Coverage
Anti-hypertensive
Acceso en línea:http://sedici.unlp.edu.ar/handle/10915/119941
Aporte de:
SEDICI (UNLP) de Universidad Nacional de La Plata
id I19-R120-10915-119941
record_format dspace
institution Universidad Nacional de La Plata
institution_str I-19
repository_str R-120
collection SEDICI (UNLP)
language Inglés
topic Ciencias Médicas
Health
Policies
Medicines
Me too
Economical Burden
Coverage
Anti-hypertensive
spellingShingle Ciencias Médicas
Health
Policies
Medicines
Me too
Economical Burden
Coverage
Anti-hypertensive
Marín, Gustavo Horacio
Marín, Lupe
Agüero, Daniel
Marin, Gina
Pagnotta, Mariana
Blanco, Luis
Budgetary Impact of Covering “Me-Too” Drugs from Social Security: Buenos Aires State Case Report
topic_facet Ciencias Médicas
Health
Policies
Medicines
Me too
Economical Burden
Coverage
Anti-hypertensive
description The majority of new drugs registered at Health Global Market are not considered real innovations and due to their chemical structure similarity of reference’s group drug, they are known as “me-too”. These “me too” drugs usually has no additional therapeutic benefits but greatly increasing treatment cost. Purpose: To demonstrate the economic impact in Social Security budget by covering “me too” medicines. Methods: An epidemiological-descriptive-analytical study was performed in order to analyze the burden of anti-hypertensive prescription from patients under coverage by Buenos Aires State Social Security (SS). Two types of medicines were compared: “pioneer/classic” or “me-too”. Variables considered were: medicine type, therapeutical group, global costs, burden for SS and for patients. Results: From 185865 patients with hypertension treated; in 121748 of the cases the strategy was monotherapy while 64117 of them received at least two or more medicines. 189714 were reference drugs while 64393 were considered “me-too”. In average, “me-too” drugs were 41.23% more expensive than classical treatment. The percentage covered by SS varies according to the medicines (between 45 to 51%) and patients must complete the amount of money remaining from their pockets. Paradoxically, the percentage covered by SS of some “me-too” were greater than coverage for most classic medications of each group. Conclusions: By only choosing the drug of reference from each therapeutical group with has proven effectiveness, the Social Security might increase the coverage to 100% of the cost of all anti-hypertensive treatment for all patients; and even that, still saving almost 2 million dollars per year
format Articulo
Articulo
author Marín, Gustavo Horacio
Marín, Lupe
Agüero, Daniel
Marin, Gina
Pagnotta, Mariana
Blanco, Luis
author_facet Marín, Gustavo Horacio
Marín, Lupe
Agüero, Daniel
Marin, Gina
Pagnotta, Mariana
Blanco, Luis
author_sort Marín, Gustavo Horacio
title Budgetary Impact of Covering “Me-Too” Drugs from Social Security: Buenos Aires State Case Report
title_short Budgetary Impact of Covering “Me-Too” Drugs from Social Security: Buenos Aires State Case Report
title_full Budgetary Impact of Covering “Me-Too” Drugs from Social Security: Buenos Aires State Case Report
title_fullStr Budgetary Impact of Covering “Me-Too” Drugs from Social Security: Buenos Aires State Case Report
title_full_unstemmed Budgetary Impact of Covering “Me-Too” Drugs from Social Security: Buenos Aires State Case Report
title_sort budgetary impact of covering “me-too” drugs from social security: buenos aires state case report
publishDate 2020
url http://sedici.unlp.edu.ar/handle/10915/119941
work_keys_str_mv AT maringustavohoracio budgetaryimpactofcoveringmetoodrugsfromsocialsecuritybuenosairesstatecasereport
AT marinlupe budgetaryimpactofcoveringmetoodrugsfromsocialsecuritybuenosairesstatecasereport
AT aguerodaniel budgetaryimpactofcoveringmetoodrugsfromsocialsecuritybuenosairesstatecasereport
AT maringina budgetaryimpactofcoveringmetoodrugsfromsocialsecuritybuenosairesstatecasereport
AT pagnottamariana budgetaryimpactofcoveringmetoodrugsfromsocialsecuritybuenosairesstatecasereport
AT blancoluis budgetaryimpactofcoveringmetoodrugsfromsocialsecuritybuenosairesstatecasereport
bdutipo_str Repositorios
_version_ 1764820449096630274

Ejemplares similares